In recent analyses, frequent IDH1 mutations were observed in secondary GBMs, diffuse or anaplastic astrocytomas, oligodendrogliomas, and anaplastic oligodendrogliomas [30], [31]. This evidence concerns the gene IDH1 and oligodendroglioma.